Sanborn and Gaffar Share Clinical and Economic Treatment Insights in NSCLC

Season 4, Episode 27,   Feb 01, 2021, 08:00 PM

Headliner
Share
Subscribe
Share
Subscribe
Next
Mesa and Gerds Talk Management Strategies and Emerging Agents in Myelofibrosis
Top episodes
FDA Approval Insights: Amivantamab and Mobocertinib in EGFR Exon 20 Insertion+ NSCLC
by OncLive® On Air
Milhem Talks Mechanism of Action, Delivery Methodology, and Ongoing Trials With RP1
by OncLive® On Air
Wise Summarizes Survival Data From ARASENS and PEACE-1 in Prostate Cancer
by OncLive® On Air